177
Views
40
CrossRef citations to date
0
Altmetric
Original Articles

Combination Chemoprevention of Intestinal Carcinogenesis in a Murine Model of Familial Adenomatous Polyposis

, , , , &
Pages 30-35 | Received 11 Aug 2008, Accepted 11 Aug 2008, Published online: 10 Nov 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Christina M Laukaitis, Steven H Erdman & Eugene W Gerner. (2012) Chemoprevention in patients with genetic risk of colorectal cancers. Colorectal Cancer 1:3, pages 225-240.
Read now
Patricia A. Welsh, Suzanne Sass-Kuhn, Chethana Prakashagowda, Diane McCloskey & David Feith. (2012) Spermine synthase overexpression in vivo does not increase susceptibility to DMBA/TPA skin carcinogenesis or Min-Apc intestinal tumorigenesis. Cancer Biology & Therapy 13:6, pages 358-368.
Read now
Patricia A Thompson & Eugene W Gerner. (2009) Current concepts in colorectal cancer prevention. Expert Review of Gastroenterology & Hepatology 3:4, pages 369-382.
Read now

Articles from other publishers (37)

Parisa Zia Sarabi, Mohammad Moradi, Malihe Bagheri, Mohammad Reza Khalili, Shahrzad Moradifard, Tannaz Jamialahmadi, Faezeh Ghasemi & Amirhossein Sahebkar. (2024) A Contemporary Review on the Critical Role of Nonsteroidal Anti-inflammatory Agents in Colorectal Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry 24:8, pages 559-570.
Crossref
Edward R. Sauter & Altaf Mohammed. (2024) Natural Products for Cancer Prevention and Interception: Preclinical and Clinical Studies and Funding Opportunities. Pharmaceuticals 17:1, pages 136.
Crossref
Lifeng Yang, Yan Wang, Shasha Hu & Xiaoyan Wang. (2023) Eflornithine for chemoprevention in the high-risk population of colorectal cancer: a systematic review and meta-analysis with trial sequential analysis. Frontiers in Oncology 13.
Crossref
J. K. Stone, N. A. Mehta, H. Singh, W. El-Matary & C. N. Bernstein. (2023) Endoscopic and chemopreventive management of familial adenomatous polyposis syndrome. Familial Cancer 22:4, pages 413-422.
Crossref
Venkateshwar Madka, Jagan M. R. Patlolla, Karthikkumar Venkatachalam, Yuting Zhang, Gopal Pathuri, Nicole Stratton, Stanley Lightfoot, Naveena B. Janakiram, Altaf Mohammed & Chinthalapally V. Rao. (2023) Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats. Cancers 15:15, pages 4001.
Crossref
Sonia Coni, Rosa Bordone, Devon Michael Ivy, Zuleyha Nihan Yurtsever, Laura Di Magno, Rodrigo D'Amico, Bianca Cesaro, Alessandro Fatica, Francesca Belardinilli, Francesca Bufalieri, Marella Maroder, Enrico De Smaele, Lucia Di Marcotullio, Giuseppe Giannini, Enzo Agostinelli & Gianluca Canettieri. (2023) Combined inhibition of polyamine metabolism and eIF5A hypusination suppresses colorectal cancer growth through a converging effect on MYC translation. Cancer Letters 559, pages 216120.
Crossref
Jason A. Zell, Thomas H. Taylor, C. Gregory Albers, Joseph C. Carmichael, Christine E. McLaren, Lari Wenzel & Michael J. Stamos. (2023) Phase IIa Clinical Biomarker Trial of Dietary Arginine Restriction and Aspirin in Colorectal Cancer Patients. Cancers 15:7, pages 2103.
Crossref
Eugénie Chevalier & Robert Benamouzig. (2023) Chemoprevention in hereditary digestive neoplasia: A comprehensive review. Therapeutic Advances in Gastroenterology 16.
Crossref
Qi-Zhang Li, Zan-Wen Zuo, Ze-Rong Zhou & Yan Ji. (2021) Polyamine homeostasis-based strategies for cancer: The role of combination regimens. European Journal of Pharmacology 910, pages 174456.
Crossref
Phillip M. Kemp Bohan, Gautam Mankaney, Timothy J. Vreeland, Robert C. Chick, Diane F. Hale, Jessica L. Cindass, Annelies T. Hickerson, Daniel C. Ensley, Vance Sohn, G. Travis Clifton, George E. Peoples & Carol A. Burke. (2020) Chemoprevention in familial adenomatous polyposis: past, present and future. Familial Cancer 20:1, pages 23-33.
Crossref
Jing Wang, Bi'e Tan, Jianjun Li, Xiangfeng Kong, Minjie Tan & Guoyao Wu. (2020) Regulatory role of l-proline in fetal pig growth and intestinal epithelial cell proliferation. Animal Nutrition 6:4, pages 438-446.
Crossref
Margie L. Clapper, Wen-Chi L. Chang & Harry S. Cooper. (2020) Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention. Cancer Prevention Research 13:3, pages 229-240.
Crossref
Jennifer K. Maratt & Elena M. Stoffel. 2020. Management of Hereditary Colorectal Cancer. Management of Hereditary Colorectal Cancer 81 101 .
David C. Montrose & Lorenzo Galluzzi. 2019. Cellular Nutrient Utilization and Cancer. Cellular Nutrient Utilization and Cancer 1 26 .
Eugene W. Gerner, Elizabeth Bruckheimer & Alfred Cohen. (2018) Cancer pharmacoprevention: Targeting polyamine metabolism to manage risk factors for colon cancer. Journal of Biological Chemistry 293:48, pages 18770-18778.
Crossref
Tracy Murray-Stewart & Robert Casero. (2017) Regulation of Polyamine Metabolism by Curcumin for Cancer Prevention and Therapy. Medical Sciences 5:4, pages 38.
Crossref
Swati Chandra, Ariel C. Nymeyer, Photini Faith Rice, Eugene W. Gerner & Jennifer K. Barton. (2017) Intermittent Dosing with Sulindac Provides Effective Colorectal Cancer Chemoprevention in the Azoxymethane-Treated Mouse Model. Cancer Prevention Research 10:8, pages 459-466.
Crossref
Miguel Crespo, Eduardo Vilar, Su-Yi Tsai, Kyle Chang, Sadaf Amin, Tara Srinivasan, Tuo Zhang, Nina H Pipalia, Huanhuan Joyce Chen, Mavee Witherspoon, Miriam Gordillo, Jenny Zhaoying Xiang, Frederick R Maxfield, Steven Lipkin, Todd Evans & Shuibing Chen. (2017) Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing. Nature Medicine 23:7, pages 878-884.
Crossref
Dora Colussi, Franco Bazzoli & Luigi Ricciardiello. (2017) Chemoprevention of Colorectal Cancer in High-Risk Patients: from Molecular Targets to Clinical Trials. Current Colorectal Cancer Reports 13:3, pages 192-204.
Crossref
Carol A. Burke, Evelien Dekker, N. Jewel Samadder, Elena Stoffel & Alfred Cohen. (2016) Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial. BMC Gastroenterology 16:1.
Crossref
Nicholas F. Evageliou, Michelle Haber, Annette Vu, Theodore W. Laetsch, Jayne Murray, Laura D. Gamble, Ngan Ching Cheng, Kangning Liu, Megan Reese, Kelly A. Corrigan, David S. Ziegler, Hannah Webber, Candice S. Hayes, Bruce Pawel, Glenn M. Marshall, Huaqing Zhao, Susan K. Gilmour, Murray D. Norris & Michael D. Hogarty. (2016) Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression. Clinical Cancer Research 22:17, pages 4391-4404.
Crossref
Dong Joon Kim, Eunmiri Roh, Mee-Hyun Lee, Naomi Oi, Do Young Lim, Myoung Ok Kim, Yong-Yeon Cho, Angelo Pugliese, Jung-Hyun Shim, Hanyong Chen, Eun Jin Cho, Jong-Eun Kim, Sun Chul Kang, Souren Paul, Hee Eun Kang, Ji Won Jung, Sung-Young Lee, Sung-Hyun Kim, Kanamata Reddy, Young Il Yeom, Ann M. Bode & Zigang Dong. (2016) Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity. Cancer Research 76:5, pages 1146-1157.
Crossref
Susan LeGendre-McGheePhotini S. RiceR. Andrew WallKyle J. SpruteRamireddy BommireddyAmber M. LuttmanRaymond B. NagleEdward R. AbrilKatrina FarrellChiu-Hsieh HsuDenise J. RoeEugene W. GernerNatalia A. IgnatenkoJennifer K. Barton. (2015) Time-serial Assessment of Drug Combination Interventions in a Mouse Model of Colorectal Carcinogenesis Using Optical Coherence Tomography. Cancer Growth and Metastasis 8s1, pages CGM.S21216.
Crossref
MICHELE LINSALATA, ANTONELLA ORLANDO & FRANCESCO RUSSO. (2014) Pharmacological and dietary agents for colorectal cancer chemoprevention: Effects on polyamine metabolism (Review). International Journal of Oncology 45:5, pages 1802-1812.
Crossref
Ann M. Bode & Zigang Dong. 2014. Cancer Prevention. Cancer Prevention 1 32 .
Altaf Mohammed, Naveena B Janakiram, Misty Brewer, Krishna Vedala, Vernon E Steele & Chinthalapally V Rao. (2013) Multitargeted Low-Dose GLAD Combination Chemoprevention: A Novel and Promising Approach to Combat Colon Carcinogenesis. Neoplasia 15:5, pages 481-IN5.
Crossref
Carl-Christer Johansson, Peter Gennemark, Per Artursson, Angela Äbelö, Michael Ashton & Rasmus Jansson-Löfmark. (2013) Population pharmacokinetic modeling and deconvolution of enantioselective absorption of eflornithine in the rat. Journal of Pharmacokinetics and Pharmacodynamics 40:1, pages 117-128.
Crossref
Eugene W. Gerner. (2012) Abstract CN04-03: Development of NSAID eflornithine combinations for treating cancer risk factors. Cancer Prevention Research 5:11_Supplement, pages CN04-03-CN04-03.
Crossref
C. C. Wong, Ka-Wing Cheng & Basil Rigas. (2012) Preclinical Predictors of Anticancer Drug Efficacy: Critical Assessment with Emphasis on Whether Nanomolar Potency Should Be Required of Candidate Agents: TABLE 1. Journal of Pharmacology and Experimental Therapeutics 341:3, pages 572-578.
Crossref
Christina M. Laukaitis & Eugene W. Gerner. (2011) DFMO: Targeted risk reduction therapy for colorectal neoplasia. Best Practice & Research Clinical Gastroenterology 25:4-5, pages 495-506.
Crossref
Brian Kim & Francis M. Giardiello. (2011) Chemoprevention in familial adenomatous polyposis. Best Practice & Research Clinical Gastroenterology 25:4-5, pages 607-622.
Crossref
Edwin A. Paz, Jenaro Garcia-Huidobro & Natalia A. Ignatenko. 2011. 45 70 .
R. Jansson‐Löfmark, S. Römsing, E. Albers & M. Ashton. (2009) Determination of eflornithine enantiomers in plasma by precolumn derivatization with o ‐phthalaldehyde‐ N ‐acetyl‐ l ‐cysteine and liquid chromatography with UV detection . Biomedical Chromatography 24:7, pages 768-773.
Crossref
Yuan Zhao, Yubin Hao, Hongguang Ji, Yayin Fang, Yinhan Guo, Wei Sha, Yanfei Zhou, Xiaowu Pang, William M. Southerland, Joseph A. Califano & Xinbin Gu. (2010) Combination Effects of Salvianolic Acid B with Low-Dose Celecoxib on Inhibition of Head and Neck Squamous Cell Carcinoma Growth In vitro and In vivo . Cancer Prevention Research 3:6, pages 787-796.
Crossref
Nathaniel S. RialFrank L. MeyskensJrJrEugene W. Gerner. (2009) Polyamines as mediators of APC-dependent intestinal carcinogenesis and cancer chemoprevention. Essays in Biochemistry 46, pages 111-124.
Crossref
Amelie Boquoi, Tina Chen & Greg H. Enders. (2009) Chemoprevention of Mouse Intestinal Tumorigenesis by the Cyclin-Dependent Kinase Inhibitor SNS-032. Cancer Prevention Research 2:9, pages 800-806.
Crossref
Eugene W. Gerner & Frank L. MeyskensJr.Jr.. (2009) Combination Chemoprevention for Colon Cancer Targeting Polyamine Synthesis and Inflammation. Clinical Cancer Research 15:3, pages 758-761.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.